Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

Zydus Lifesciences reacted sharply to the development in Tuesday's trade with the counter rising 5.23 percent to an intraday high of Rs 1,011.75 per share on the NSE.

Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune of $7.3 billion over six years ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

FTC Chair Lina Khan has the big three pharmacy benefit managers in sight—UnitedHealth's OptumRx, Cigna's Express Scripts and CVS Caremark Rx. © 2024 Fortune Media ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Currently, CVS Health has an average volume of 13.79M. TipRanks tracks over 100,000 company insiders ... a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health ...

The report accuses CVS’ Caremark, Cigna’s Express Scripts and ... revenue grew at a compound annual growth rate of 42% over the study period, the FTC said. Meanwhile, plan and patient costs ...

and sells prescription and over-the-counter medications. The company also offers health and beauty products, pharmacy consulting, and services to care facilities. CVS Health Corporation (NYSE ...